Live longer - Combination therapy with Rapamycin and Trametinib prolongs the life of mice

Researchers at the Max Planck Institute for Biology of Ageing have discovered that the combination of the two cancer drugs Rapamycin and Trametinib significantly extends the lifespan of mice. This therapy shows greater effects than the individual drugs and offers not only a longer lifespan, but also health benefits in old age. The results suggest that this drug combination could be a promising strategy for combating age-related diseases and promoting longevity.